Norges Bank
PRTK

Norges Bank’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Norges Bank’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-66,600
Closed -$198K – 2199
2022
Q1 		$198K Sell
66,600
-12,600
-16% -$47.4K ﹤0.01% 2139
2021
Q4 		$356K Sell
79,200
-27,600
-26% -$131K ﹤0.01% 2161
2021
Q3 		$519K Sell
106,800
-50,400
-32% -$278K ﹤0.01% 2200
2021
Q2 		$1.07M Buy
+157,200
New +$1.27M ﹤0.01% 2109
2020
Q1 		– Sell
-289,008
Closed -$1.17M – 2084
2019
Q4 		$1.17M Hold
289,008
– – ﹤0.01% 2014
2019
Q3 		$1.25M Hold
289,008
– – ﹤0.01% 2021
2019
Q2 		$1.15M Sell
289,008
-187,969
-39% -$894K ﹤0.01% 2027
2019
Q1 		$2.56M Hold
476,977
– – ﹤0.01% 1999
2018
Q4 		$2.45M Hold
476,977
– – ﹤0.01% 1989
2018
Q3 		$4.63M Hold
476,977
– – ﹤0.01% 1976
2018
Q2 		$4.87M Hold
476,977
– – ﹤0.01% 1955
2018
Q1 		$6.2M Sell
476,977
-50,000
-9% -$744K ﹤0.01% 1858
2017
Q4 		$9.43M Hold
526,977
– – ﹤0.01% 1758
2017
Q3 		$13.2M Buy
526,977
+212,323
+67% +$4.94M 0.01% 1648
2017
Q2 		$7.58M Buy
314,654
+218,154
+226% +$4.82M ﹤0.01% 1817
2017
Q1 		$1.86M Hold
96,500
– – ﹤0.01% 2001
2016
Q4 		$1.49M Buy
96,500
+75,187
+353% +$976K ﹤0.01% 1992
2016
Q3 		$265K Hold
21,313
– – ﹤0.01% 2131
2016
Q2 		$296K Hold
21,313
– – ﹤0.01% 2146
2016
Q1 		$323K Hold
21,313
– – ﹤0.01% 2153
2015
Q4 		$404K Hold
21,313
– – ﹤0.01% 2185
2015
Q3 		$405K Hold
21,313
– – ﹤0.01% 2210
2015
Q2 		$549K Buy
+21,313
New +$605K ﹤0.01% 2178

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Norges Bank's PRTK Position: Q2 2022 in Review

Norges Bank sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 66,600 shares — an estimated $198K sold.

Norges Bank first reported a position in PRTK in Q2 2015 and held it in 23 quarters. The position peaked at $13.2M in Q3 2017. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • Norges Bank reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Norges Bank sold 66,600 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $198K.
  • Norges Bank first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and held it in 23 quarters.
  • Norges Bank's Paratek Pharmaceuticals, Inc. position peaked at $13.2M in Q3 2017.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.